Literature DB >> 17966528

Hospital cost-categories of pancreaticoduodenectomy.

B Topal1, G Peeters, H Vandeweyer, R Aerts, F Penninckx.   

Abstract

AIMS: In the era of cost-conscious healthcare, hospitals are focusing on costs. Analysis of hospital costs per cost-category may provide indications for potential cost saving measures in pancreaticoduodenectomy (PD).
METHODS: Between January 2004 and June 2005, 109 consecutive patients underwent curative PD for a pancreatic or peri-ampullary tumour. Costs were defined in different cost categories for each activity centre and were linked to the individual patient via the 'bill of activities'.
RESULTS: Postoperative complication rate was 46.8%, postoperative pancreatic fistula (POPF) 12.8%, and mortality rate 1.8%. The overall median LOS was 17 (range 7-52) days. The length of hospital stay (LOS) was significantly (p < 0.0001) different between patients with POPF, those with other complications, and patients without complications i.e. 26 (10-36) vs. 21 (8-52) vs. 14 (7-33) days, respectively. Median hospital cost per patient was 10406 (5570-30999) euros. The total hospital costs were significantly related to the LOS (p < 0.0001). The increase of total hospital costs was influenced by the hospitalization (p < 0.0001) and medical staff (p < 0.0001) costs, but not by the cost for the operation room (p = 0.233).
CONCLUSION: Postoperative complications, in particular POPF, are associated with increased LOS and higher hospital costs. Any measure to reduce the incidence and severity of complications after PD will save hospital costs.

Entities:  

Mesh:

Year:  2007        PMID: 17966528     DOI: 10.1080/00015458.2007.11680078

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  5 in total

1.  Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy.

Authors:  Jordan M Cloyd; Zachary J Kastenberg; Brendan C Visser; George A Poultsides; Jeffrey A Norton
Journal:  J Gastrointest Surg       Date:  2013-08-01       Impact factor: 3.452

2.  Pancreaticoduodenectomy hospital resource utilization in octogenarians.

Authors:  Russell C Langan; Chun-Chih Huang; Weisheng Renee Mao; Katherine Harris; Will Chapman; Charles Fehring; Kesha Oza; Patrick G Jackson; Reena Jha; Nadim Haddad; John Carroll; Jane Hanna; Ann Parker; Waddah B Al-Refaie; Lynt B Johnson
Journal:  Am J Surg       Date:  2015-06-04       Impact factor: 2.565

3.  Costs and trends in pancreatic cancer treatment.

Authors:  Caitriona B O'Neill; Coral L Atoria; Eileen M O'Reilly; Jennifer LaFemina; Martin C Henman; Elena B Elkin
Journal:  Cancer       Date:  2012-03-13       Impact factor: 6.860

4.  Pancreatoduodenectomy for ductal adenocarcinoma in the very elderly; is it safe and justified?

Authors:  Saboor Khan; Guido Sclabas; Kaye Reid Lombardo; Michael G Sarr; David Nagorney; Michael L Kendrick; John H Donohue; Florencia G Que; Michael B Farnell
Journal:  J Gastrointest Surg       Date:  2010-08-17       Impact factor: 3.452

5.  Hospital-level resource use by the oldest-old for pancreaticoduodenectomy at high-volume hospitals.

Authors:  Russell C Langan; Chaoyi Zheng; Katherine Harris; Richard Verstraete; Waddah B Al-Refaie; Lynt B Johnson
Journal:  Surgery       Date:  2015-05-23       Impact factor: 3.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.